Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Goldschmidt

Showing results (411-420 of 472) with videos related to

Pageof 48
Sort By:
Cancer Medicine|November 14, 2023
Real-world outcomes of 18,186 metastatic solid tumor outpatients: Baseline blood cell counts correlate with survival after immune checkpoint inhibitor therapyJerome H Goldschmidt, Lin-Na Chou, Philip K Chan, et al.
European Radiology|November 1, 2014
The application of Gadopentate-Dimeneglumin has no impact on progression free and overall survival as well as renal function in patients with monoclonal plasma cell disorders if general precautions are takenJ Hillengass, J Stoll, C M Zechmann, et al.
Bone Marrow Transplantation|September 25, 2007
Lack of CD56 expression on myeloma cells is not a marker for poor prognosis in patients treated by high-dose chemotherapy and is associated with translocation t(11;14)M Hundemer, U Klein, D Hose, et al.
Cancer Genetics and Cytogenetics|May 10, 2006
Chromosomal aberrations in 130 patients with multiple myeloma studied by interphase FISH: diagnostic and prognostic relevanceI G H Schmidt-Wolf, A Glasmacher, C Hahn-Ast, et al.
Leukemia|August 21, 2013
Prognostic significance of whole-body MRI in patients with monoclonal gammopathy of undetermined significanceJ Hillengass, M-A Weber, K Kilk, et al.
International Journal of Hematology|April 26, 2013
Bisphosphonate treatment and renal function in 201 myeloma patients undergoing stem cell transplantationS Schmitt, T Hielscher, C Baldus, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2013
Autologous stem cell transplantation for elderly patients with newly diagnosed multiple myeloma in the era of novel agentsM Merz, K Neben, M S Raab, et al.
Bone Marrow Transplantation|April 24, 2007
Efficient mobilization of peripheral blood stem cells following CAD chemotherapy and a single dose of pegylated G-CSF in patients with multiple myelomaS Fruehauf, J Klaus, J Huesing, et al.
Swiss Medical Weekly|July 19, 2006
Clinical significance of cyclooxygenase-2 (COX-2) in multiple myelomaA Trojan, M Tinguely, S Vallet, et al.
The Annals of Otology, Rhinology, and Laryngology|November 2, 2021
Otoendoscopes to Enhance Telemedicine During the COVID-19 PandemicEvette A Ronner, Matthew E Stenerson, Nicole H Goldschmidt, et al.
Pageof 48

Showing results (411-420 of 472) with videos related to

Sort By:
Pageof 48
Cancer Medicine|November 14, 2023
Real-world outcomes of 18,186 metastatic solid tumor outpatients: Baseline blood cell counts correlate with survival after immune checkpoint inhibitor therapyJerome H Goldschmidt, Lin-Na Chou, Philip K Chan, et al.
European Radiology|November 1, 2014
The application of Gadopentate-Dimeneglumin has no impact on progression free and overall survival as well as renal function in patients with monoclonal plasma cell disorders if general precautions are takenJ Hillengass, J Stoll, C M Zechmann, et al.
Bone Marrow Transplantation|September 25, 2007
Lack of CD56 expression on myeloma cells is not a marker for poor prognosis in patients treated by high-dose chemotherapy and is associated with translocation t(11;14)M Hundemer, U Klein, D Hose, et al.
Cancer Genetics and Cytogenetics|May 10, 2006
Chromosomal aberrations in 130 patients with multiple myeloma studied by interphase FISH: diagnostic and prognostic relevanceI G H Schmidt-Wolf, A Glasmacher, C Hahn-Ast, et al.
Leukemia|August 21, 2013
Prognostic significance of whole-body MRI in patients with monoclonal gammopathy of undetermined significanceJ Hillengass, M-A Weber, K Kilk, et al.
International Journal of Hematology|April 26, 2013
Bisphosphonate treatment and renal function in 201 myeloma patients undergoing stem cell transplantationS Schmitt, T Hielscher, C Baldus, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2013
Autologous stem cell transplantation for elderly patients with newly diagnosed multiple myeloma in the era of novel agentsM Merz, K Neben, M S Raab, et al.
Bone Marrow Transplantation|April 24, 2007
Efficient mobilization of peripheral blood stem cells following CAD chemotherapy and a single dose of pegylated G-CSF in patients with multiple myelomaS Fruehauf, J Klaus, J Huesing, et al.
Swiss Medical Weekly|July 19, 2006
Clinical significance of cyclooxygenase-2 (COX-2) in multiple myelomaA Trojan, M Tinguely, S Vallet, et al.
The Annals of Otology, Rhinology, and Laryngology|November 2, 2021
Otoendoscopes to Enhance Telemedicine During the COVID-19 PandemicEvette A Ronner, Matthew E Stenerson, Nicole H Goldschmidt, et al.
Pageof 48